Fermenta Biotech Limited (BOM:506414)

Fermenta Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	316.95	282.4	218.29	352.91	130.56
Short-Term Investments	10.64	424.2	379.95	247.68	126.37
Cash & Short-Term Investments	327.58	706.59	598.24	600.59	256.93
Cash Growth	-53.64%	18.11%	-0.39%	133.75%	-29.35%
Accounts Receivable	1,172	1,041	729.75	448.69	870.9
Other Receivables	533.1	153.18	9.39	3.51	79.03
Receivables	1,706	1,205	785.78	462.45	950.08
Inventory	1,614	1,329	890.75	1,312	1,733
Prepaid Expenses	41.76	23.27	51.7	26.77	27.85
Restricted Cash	78.32	-	0	3.84	0.13
Other Current Assets	112.24	88.96	91.07	125.02	172.01
Total Current Assets	3,880	3,352	2,418	2,530	3,140
Property, Plant & Equipment	2,233	2,322	2,535	2,585	2,373
Long-Term Investments	4.3	4.86	4.43	3.76	48.93
Goodwill	41.17	41.17	41.17	115.3	109.55
Other Intangible Assets	26.17	29.98	71.55	132.72	175.95
Long-Term Deferred Tax Assets	183.59	286.44	219.99	332.58	359.94
Long-Term Deferred Charges	0.49	0.82	1.15	-	0.16
Other Long-Term Assets	98.48	105.38	184.8	664.14	860.34
Total Assets	6,479	6,145	5,478	6,365	7,068

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	771.5	774.87	649.04	457.95	645.8
Accrued Expenses	60.75	49.94	81.86	40	68.96
Short-Term Debt	914.97	812.4	673.42	1,015	974.75
Current Portion of Long-Term Debt	94.89	131.13	223.93	318	239.88
Current Portion of Leases	12.63	10.92	9.58	6.87	10.7
Current Income Taxes Payable	18.43	44.11	3.41	3.25	3.2
Current Unearned Revenue	17.3	190.09	3	0.95	-
Other Current Liabilities	197.27	105.31	88.36	245.6	127.94
Total Current Liabilities	2,088	2,119	1,733	2,087	2,071
Long-Term Debt	78.99	150.48	425.36	835.89	1,147
Long-Term Leases	31.81	44.44	55.39	19.91	19.68
Pension & Post-Retirement Benefits	66.19	41.38	25.62	21.43	18.85
Other Long-Term Liabilities	209.2	204.54	387.7	275.1	97.32
Total Liabilities	2,474	2,560	2,627	3,240	3,354

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	143.35	145.85	144.37	144.29	144.24
Additional Paid-In Capital	171.62	171.23	23.69	15.28	-
Retained Earnings	4,276	3,628	2,903	3,169	3,618
Treasury Stock	-170.32	-	-	-	-
Comprehensive Income & Other	-358.09	-318.36	-182.93	-174.98	-41.28
Total Common Equity	4,062	3,627	2,889	3,153	3,721
Minority Interest	-56.68	-41.57	-36.98	-27.49	-6.83
Shareholders' Equity	4,005	3,585	2,852	3,126	3,715
Total Liabilities & Equity	6,479	6,145	5,478	6,365	7,068

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,133	1,149	1,388	2,195	2,392
Net Cash (Debt)	-805.71	-442.76	-789.44	-1,595	-2,135
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-27.52	-15.18	-27.34	-55.26	-73.61
Filing Date Shares Outstanding	28.67	29.43	29.43	28.86	28.85
Total Common Shares Outstanding	28.67	29.43	29.43	28.86	28.85
Working Capital	1,792	1,234	684.93	443.05	1,069
Book Value Per Share	141.68	123.23	98.15	109.27	129.00
Tangible Book Value	3,995	3,556	2,776	2,905	3,436
Tangible Book Value Per Share	139.33	120.81	94.32	100.67	119.10
Land	3.43	3.43	3.43	3.43	3.43
Buildings	1,065	1,010	1,007	717.57	701.21
Machinery	2,221	2,140	2,101	1,892	1,799
Construction In Progress	127.9	159.07	16.16	419.03	298.93
Leasehold Improvements	59.13	59.13	211.64	211.64	49.86

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error